Peter Canoll

10PUBLICATIONS
56CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursBiologically active moleculesMicrobial geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor.

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Dec 31, 2025
A two-step screen identifies a small molecule that disrupts membrane voltage and is effective against growing and persister gram-negative bacteria.

Ciara K Asamoto, Calvin A Ewing, Christian T Meyer

|Mar 05, 2025
A high-throughput anaerobic method for viability assays.

Mohamed El-Fateh, Christian T Meyer, Anushree Chatterjee

|Aug 21, 2024
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies.

Christian T Meyer, Brianna N Smith, Jing Wang

|Jun 19, 2024
Resistance to Spindle Inhibitors in Glioblastoma Depends on STAT3 and Therapy Induced Senescence.

Natanael Zarco, Athanassios Dovas, Virginea de Araujo Farias

Pageof 2

Frequent Collaborators

3 joint publications

Joel M Kralj

2 joint publications

Anushree Chatterjee

2 joint publications

Vito Quaranta

1 joint publications

Megan P Jewell